Ingalls & Snyder LLC Pfizer Inc Call Options Transaction History

Ingalls & Snyder LLC

  • $2.33 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Jul 31, 2024
SELL
$25.26 - $29.6 $17,682 - $20,720
-700 Reduced 1.18%
58,400 $1.63 Million
Q1 2024

May 13, 2024
BUY
$25.89 - $29.73 $854,370 - $981,090
33,000 Added 126.44%
59,100 $1.64 Million
Q4 2023

Jan 29, 2024
BUY
$26.13 - $33.94 $681,993 - $885,833
26,100 New
26,100 $751,000

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email